chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2/15/2023: CLINICAL IMPRESSION: Fall, initial encounter Injury of head, initial encounter Hypoxia COVID-19 68-year-old male presents after unwitnessed fall, with abrasion over the right periorbital region. He is also hypoxic down to 86% on room air recently diagnosed with COVID. Given this he was given Decadron, supplemental nasal cannula oxygen with improvement in his oxygen saturations. He does not appear to be in any respiratory distress. His CBC does note a white count of 12.29 COVID-10 -will start remdesivir due to risk of progression  Submitter does not have access to further medical records or information on hospital course. If further information is needed, please contact  admitting hospital:
Information has been received via the Merck Pregnancy registry from a consumer, concerning her daughter (age not specified) who was pregnant when vaccinated on 14-AUG-2007, with a dose of Gardasil (lot # not specified). The mother stated that "the fetus had no heartbeat," and indicated that her daughter had a miscarriage (date not provided). At the time of this report, the outcome of miscarriage was unknown. The consumer's daughter sought unspecified medical attention from her physician. Additional information has been requested.
pt recv vax 5JAN99 1wk later pt devel diaper dermatitis w/blistering; The parents reported that pt diapers emitted an acidic smell;
Vax administered on 4/1/03. PT with erythema at inject site on 4/2/03. Gradually increase in size since then. On 4/3/03 ED for cellulitis - abx (antibiotics) started.
Bleeding at the injection site and by the next day, bleeding from a 40 year old smallpox vaccination site on the left arm near the vaccine injection site
Within 3 hours, full body aches, chills, shivering, aching joints, tender skin, hive-like full body itching but without hive bumps, sore muscles, sore neck, headache, extreme fatigue, weakness, shortness of breath, nausea. It lasted at that severe stage for 32 hours and then subsided SLOWLY over the next week. It finally left after 10 days. I was super weak.
On the 1/11/2021 I noted a discoloration to the outer left axilla area- resembling bruising, and a round, flat rash like area.  I have swelling to my left axilla, with 3 points of pain with palpation within it.  I also have tenderness in my left breast closest to my axilla.
Had vaccine, still got Shingles\ suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient stated he/she had Shingles vaccine and still got Shingles. It was a mild case and caught early. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.
swollen lymph node developed; Headache; I was tired; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swollen lymph node developed), HEADACHE (Headache) and FATIGUE (I was tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 032L2*A) for COVID-19 vaccination.     The patient's past medical history included Anaphylactic reaction (To Amifostine 20 years ago). Previously administered products included for an unreported indication: AMIFOSTINE (20 years ago). Concurrent medical conditions included Cancer. Concomitant products included OLAPARIB (LYNPARZA) for Cancer.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (swollen lymph node developed), HEADACHE (Headache) and FATIGUE (I was tired). At the time of the report, LYMPHADENOPATHY (swollen lymph node developed), HEADACHE (Headache) and FATIGUE (I was tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Mammogram: swollen lymph node.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Treatment medication was not reported.
Mom said about 4 hours after she left the office the baby cried inconsolably for 2 hours. She took him to ER and they said he was fine & he stopped crying. She came to office next day because he was taking his bottle well & was just laying. In the office he was alert & playful and he took about 6 oz of formula.
Rash, Arthralgia, Fever - information has been received from a pharmacist concerning a 49 year old female patient with no known allergies who on 28 Sep 2000 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live second geneartion lot 633094/0177k.  Subsequently 14 days later, the patient experienced a  fine rash, fever (temp ranges not given) and joint aches.  The pharmacist said the patient probably had measles before vaccination.  The patient sought unspecified medical attention.  Additional information has been requested.
Awoke at 0430.  Went down 1 flight of stairs about 10 minutes later.  Walked a few  few steps became extremely nauseated, ears ringing, tunnel vision,  clammy, very dizzy and light headed.  Went back to stairs to sit down so I wouldn?t pass out.  Sat on stairs for at least 10 minutes.  Ears still ringing, vision filed not back to normal and nauseated. Crawled to sink to get drink of water.   Went to recliner, stayed in recliner most of day.  Went to primary care physician next day.
Bleeding reports he woke up 'peeing blood' this morning. reports no other symptoms Narrative:
1 week long dizziness, brain fog, numbness in lower left leg, stomach issues.
3 months after receiving 2nd dose of covid vaccine I experienced 3 upper respiratory infections just a few weeks apart, a throat infection after that, and lymphadenopathy shortly after that.  Bartonella Disease  (Cat scratch fever)  was ruled out as causing the cat scratch fever via lab test. Prior to receiving covid vaccines I was never sick.
Patient has been experience pain in the arm of the site injection still after the injection on 04.01.2021 when reported to pharmacy on 04.12.2021 by phone.
Information has been received from a consumer concerning a 17 year old female with sulfur allergy and asthma who on 11-JUL-2007 was vaccinated with the first GARDASIL (lot # 657868/0523U), on 05-SEP-2007 with the second dose of GARDASIL (lot # 658490/0802U) and on 20-FEB-2008 with the third dose of GARDASIL (lot # 657868/0523U). Concomitant therapy included montelukast sodium. On 18-MAY-2008, the patient experienced blood clot at the injection site after getting the third shot of GARDASIL vaccine and was hospitalized for one day. On an unspecified date the patient recovered from blood clot at the injection site. The laboratory diagnostics study performed was blood work, factor 5 test (results not reported). The patient sought medical attention. Additional information has been requested. 10/16/08-records received for DOS 5/15-5/16/08-DC DX: Right axillary venous thrombosis. Etiology may be a hypercoagulable state from the NuvaRing versus a hypercoagulable syndrome or thrombophilia. Presented with 1 week history of pain in right arm and mild discoloration to right arm with subsequent swelling.
Pt recv vax 6Jun95.  Dec97 Pt devel chickenpox. Pt brother (WAES98010168) reported as well.
pt admitted to hospital with respiratory with hypoxia secondary to COVID pneumonia; positive test for COVID; antiviral meds, ABX, respiratory tx; respiratory status worsened; CCU; intubated; clinical condition worsened; tachycardic; oxygenation deteriorated; hypotension; DNR; transitioned to Comfort Measures; extubated and comfort meds given; pt passed away in the hospital
Complaints of chest tightness, pain, shortness of breath starting evening/night the vaccination was given. Stated more pain the deeper the breathe. Treatment: I gave him 200mg of ibuprofen. Complaint: 8/20/2015 7:00 AM Soreness and pain under left arm.  Stated he felt a "something" at site of pain. Treatment: I felt under his arm and felt slightly enlarged nodes and  there was tenderness. Applied warm compress and acetaminophen. 8/20/2015 7:00 PM - Chest pain still the same. He felt as if he were coming down with a cold, and he started coughing.  Treatment: Administered Motrin and Mucinex cold/cough.   8/21/2015 7:00 AM - Awakened to no relief from chest pain, left under arm still sore. Treatment: I took him to the health department where shot was administered, explained to nurse symptoms. I was informed the symptoms were not side affects to immunizations administered to child. I scheduled an appointment for him with PCP for 8/22/2015.
Slight rash around the injection site; Slight itchiness on my left arm near the injection site; A spontaneous report was received from a 27-year-old female consumer who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced slight itchiness on her left arm near the injection site [vaccination site pruritus] and a very slight rash around the injection site [vaccination site rash].   The patient's medical history was not provided. Concomitant product use was not provided by the reporter.    On 26-Dec-2021, approximately 8 days prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Lot number unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 03-Jan-2021, the patient noticed a slight itchiness of her left arm near the injection site. On 04-Jan-2021, she also noticed a very slight rash around the injection site. Treatment information was not provided.   Action taken with mRNA-1273 in response to the events was not provided.   The outcome of the events was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported events, a causal relationship cannot be excluded.
The next day I felt bad, lethargic and feverish. I layed around for several days. I did not seek any treatment.
4/3/13 - Pt received ZOSTAVAX, lt upper arm SQ. 4/7/14 - Pt seen for rash to his lt wrist and forearm. Reports rash appeared after vaccine.
Blood in pee; This is a spontaneous report from a contactable consumer (patient).  A 31-year-old female (not pregnant) patient received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in the left arm, on 23Aug2021 at 12:45 (Batch/Lot Number: Fc3181), at the age of 31 years old, as 1st single dose, for COVID-19 immunisation. Medical history included fatty liver disease, esophilic esophagitis, atrial fibrillation, all from 2019, and no periods due to birth control. There were no known allergies. Concomitant medications included colecalciferol (VITAMIN D 3), and phentermine (PHENTERMINE). The patient had not received any other vaccines in the 4 weeks prior to BNT162b2 vaccination. The patient never had COVID prior to vaccination. The patient complained about blood in pee on 23Aug2021 at 13:45 and specified that she no longer had periods anymore due to birth control. No treatment was required for the event. The patient had a COVID test (nasal swab) post vaccination on 23Aug2021 that resulted negative. The patient had not recovered from the event.   Follow-up attempts are completed. No further information is expected.
Swollen lymph nodes; This is a spontaneous report from a contactable consumer (patient). A 47-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6207) via an unspecified route of administration, in right arm on 19Mar2021 (at the age of 47-year-old) at single dose for COVID-19 immunization. The patient's medical history included hypothyroidism and asthma. The patient has no allergies to medications, food, or other products. The patient's concomitant medications included unspecified thyroid medication. The patient was not pregnant and didn't receive any other vaccines within four weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient hasn't been tested for COVID-19. The patient experienced swollen lymph nodes on 23Mar2021. The patient didn't receive any treatment for the event. Outcome of the event was not resolved.  No follow-up attempts are possible. No further information is expected.
Macular rash to right deltoid. No swelling of limb, not warm, not tender.
Patient received vaccine in clinic around 10:20am.  Patient waited around the pharmacy for around 20 min and then left.  Patient returned around 11-11:10 am with his mother in which we were notified that he was having a reaction.  We brought the patient into the patient care room in which he was vomiting and patient's mother stated that he had a seizure.  Patient was conscious but had some altered mental status.  Patient denied any falls.  911 was called and EMS took patient to the hospital.
Pt had Yellow Fever vaccine on 3/2/17; she rpts for 3-4 days after vaccine given she had some redness and itching and then sxs went away. Last night, 3/13/17, she noticed site where vaccine was given on Lt arm was red and w/some mild tenderness. Today she came by clinic and at site where vaccine givne she has 7.5 cm X 6.5 cm area of erythema, mild swelling & warmth; a 1 mm faint yellow papule in center. Rxed doxycycline 100mg BID; Zyrtec during day and Benadryl at PM x 5 days. She denies fever, NV. In clinic, her Temp was 97.8, pulse 52 and O2 sat 98%.
Pt called to report symptoms post pfizer vaccine #1 which she received on 4/7/21.  She began to experience symptoms 12 hrs after vaccine administration.  She felt faint, "pins and needles" all over her body, and particularly in her lips.  She reports feeling "wired" even though she was very tired.  She experienced nausea and chest tightness the next moring.  Her symptoms were gone by 4pm 4/8/21.   She is reporting this as she is worried about vaccine #2, scheduled for 4/29.  Allergy consult placed, and pt encouraged to contact her PCP re need for any cardiac work up.
For 7 days /p DPT,seemed more irritable, MNC difficult to console& feed.On 7th day episode during changing(while playful)legs suddenly straightened& stiff,arms back,staring-lasted approx 15 sec.Then crying,shaking,seemed frightened..seeWORM
Caller is confused if the Moderna shot was the 2nd primary shot or first booster; This spontaneous case was reported by an other health care professional and describes the occurrence of CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Caller is confused if the Moderna shot was the 2nd primary shot or first booster) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Janssen Vaccine (Primary series) in April 2021 and Janssen Vaccine. Past adverse reactions to the above products included No adverse event with Janssen Vaccine and Janssen Vaccine.    In October 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Caller is confused if the Moderna shot was the 2nd primary shot or first booster). At the time of the report, CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Caller is confused if the Moderna shot was the 2nd primary shot or first booster) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It is reported that age of the patient was < 50-year. No concomitant medications were reported.  Patient stated like that J&J came out with a 2nd vaccine but she was not sure if the 2nd J&J vaccine was a booster or a primary dose, in which case the Moderna Shot might had been part of primary shots mixed with J & J.  No treatment medications were reported.   Reporter did not allow further contact
Patient experienced dizziness and giddiness after vaccination . Onsite EMS was called vitals BP 169/83  99% O2 room air HR 95. Patient Treated, Transported by the EMS to the hostipal.
Information has been received from a health professional concerning a 66 year old female who was vaccinated with a dose of Pneumovax 23 (lot #654977/0888F).  Subsequently the patient experienced redness, swelling, tenderness, chills and fever.  The patient was treated with prednisone.  At the time of the report, the patient was recovering.  Additional information has been requested.
Lethargic, fever, chills, headache, lack of appetite, sore hands/feet/neck This started the evening that I received the vaccine and was so ill that I missed work the next day (Tuesday). Went back to work on Wednesday and continued to have headaches and body pain for the next 8 days, took Tylenol, which helped.
The day following the vaccination, the injection site was swollen the size of a baseball, red and hot to the touch. It was very hard. The doctor stated it was a "hard local reaction". The patient was treated with Motrin and ice packs and was advised to monitor any other changes.
dark, discolored spot; dark, discolored spot that itches; This case was reported by a consumer and described the occurrence of skin discoloration in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced skin discoloration and pruritus. On an unknown date, the outcome of the skin discoloration and pruritus were not recovered/not resolved.   It was unknown if the reporter considered the skin discoloration and pruritus to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was captured as adult as per vaccine indication. At the time of reporting, the patient still had a dark, discolored spot that itches.
1 hour later had trouble swallowing; 20 minutes after injection my lips started swelling; This is a spontaneous report from a contactable consumer or other non HCP (patient). A 69-year-old non pregnant female patient received bnt162b2 (BNT162B2, formulation; solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 19Jan2021 17:00 (Batch/Lot Number: EL1283) as DOSE 1, SINGLE for covid-19 immunisation (at the age of 45-year-old). The patient was not pregnant at the time of vaccination. The patient medical history was not reported. Concomitant medication included levothyroxine sodium (SYNTHROID) taken for an unspecified indication, start and stop date were not reported (received within two weeks of vaccination). The patient had not received any other vaccine within 4 weeks. The patient previously took botox and experienced known allergies. The patient experienced 20 minutes after injection her lips started swelling and 1 hour later had trouble swallowing on 19Jan2021. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested for COVID since the vaccination. No treatment received for events. The outcome of events reported as recovered on an unspecified date of 2021.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
A physician reported via a company representative that a 2 month old infant received Prevanr vaccine (date not specified) along with three other vaccines (not identified). The following day, the infant died from SIDS. The reporting physician did not think that the vaccines had anything to do with the death. No additional information was available as of the date of this report. This report of a serious, labeled event is being submitted in a 15-day time frame, as requested. Follow up information via telephone contact was obtained from the physician on 10/03/02. She clarified the infant's age (4 months rather than 2 months) and reported that the child died as a result of co-sleeping with the parents. (Initial report)A physician reported via a company representative that a 2 month old infant received Prevnar (pneumococcal 7-valent conjugate vaccine) vaccine (date not specified) along with 3 other vaccines (not identified).The following day, the infant died from SIDS. The reporting physician did not think the vaccines had anything to do with the death. No additional information was available as of the date of this report.
Had two doses of Moderna. I have had heavyish periods but have always been extremely regular. After the second dose (4/2021), my periods became irregular, extremely debilitating, painful and ginormous amounts of blood loss and blood clots.   From the time of the second vaccine until I ultimately had to have a hysterectomy to stop the bleeding, my periods were irregular which has never happened in my life. On 10/2, I started the period that never quit! By mid-October, I was in the ER. I had almost passed out several times that day. I was anemic, dizzy and extremely exhausted. I had a vaginal ultrasound, blood work, IV fluids.  Scheduled with a GYN next day. She put me on iron, a hormone and a blood pressure pill as the stress and loss of blood had skyrocketed my blood pressure. Hormone seemed to slightly slow the bleeding for about 3-5 days-mind you still extremely heavy. Then it didn't even phase it. Tried a double dose of a different hormone to slow/stop the bleeding. Nothing! Long story short, had to have a hysterectomy on Nov 18 2021. Which, by the way I was still excessively bleeding from 10/2/21!  I hope serious research goes into this as my life and many other women's have been permanently changed!
pt recvd vax & 6 days later exp arthralgia,ankles & wrist were sore as of 27DEC94 sx substantially gone